Phreesia, Inc. announced that on July 15, 2020, Scott Perricelli, a member of the Board, notified the Company of his intent to resign from the Board, effective July 20, 2020. Mr. Perricelli’s decision to resign was not the result of any disagreement with the Company on any matters relating to the Company’s operations, policies or practices. Gillian Munson, a current member of the Board, will replace Mr. Perricelli on the Compensation Committee of the Board. On July 20, 2020, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Lainie Goldstein to the Board, effective July 20, 2020. Ms. Goldstein will serve as a Class II director of the Company, to hold office until the 2021 annual meeting of stockholders or until her earlier death, resignation or removal. Ms. Goldstein was also appointed to replace Mr. Perricelli on the Audit Committee of the Board and was designated by the Board as an audit committee financial expert under the rules and regulations of the Securities and Exchange Commission.
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.